Pfizer Inc (PFE)

$25.18 +0.28 (1.12%)
Market Cap 143.17B
Revenue (ttm) 63.63B
Net Income (ttm) 8.03B
EPS (ttm) N/A
PE Ratio 7.78
Forward PE 8.40
Profit Margin 12.62%
Debt to Equity Ratio 0.66
Volume 35,976,600
Avg Vol 67,711,563
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 51%
Beta 0.47
Analysts Sell
Price Target $27.95

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
JuggernautRaider
JuggernautRaider Jan. 4 at 9:06 PM
I’d be surprised if $NUVB is sold in 2026, but not shocked. Hung’s prior company Medivation sold to $PFE in 2016 after it was clear to their board that they didn’t have a choice. $SNY tried to buy Medvation on the cheap, and then Pfizer blew them out of the water with an offer $30 higher per share. Now, Hung has a fortune and is the largest shareholder of Nuvation by far. So he is better prepared to stay independent if that is his main goal. Some Nuvation bulls believe and want NUVB will stay independent- if they can keep finding deals like the AmHeart deal for a best in class asset like Ibtrozi then they should). I hope both NUVB and $TNXP stay independent for a while, for very different reasons. But I doubt a buyout happens this year for Nuvation given how much Hung learned from his Medivation experience.
1 · Reply
Makingmillions192
Makingmillions192 Jan. 4 at 2:38 PM
$LEXX Bottom line: we are clearly at an inflection point for this company. MTA partner has continued to show interest and the data is compelling and worth continuing. We are also at the stage where we could see new partners get involved. Very exciting times ahead 💰  $JAZZ $PFE $MRK
0 · Reply
Turbofueled
Turbofueled Jan. 4 at 1:23 PM
$LEXX Let the games begin!! I would bet bidding wars are starting! Bring It! $NVO $LLY $AZN $PFE Lets Go $LEXX
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Jan. 4 at 8:13 AM
Enter: $PFE Calls Strike Price: $26 Expiry Date: JAN 30 2026 Buy in Price: $0.20 - $0.20 Sell Price: $0.44 Profit : +122% (Turn every $1 into $2.22) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
clan
clan Jan. 4 at 7:57 AM
$MRK $PFE There's inhalable mealtime insulin. Who knew? $CIPLA.NSE
0 · Reply
twilley
twilley Jan. 4 at 4:38 AM
$PFE Pfizer acquired Amplyx in 2021. Their drug Fosmanogepix could be the next breakthrough for the Candida Auris outbreaks that are current anti fungal drug resistant.
0 · Reply
taxplanr
taxplanr Jan. 4 at 3:27 AM
Sounds like the ground work for liability for COVID jabs from $BNTX $MRNA $PFE https://www.instagram.com/reel/DTCBxDYExIc/?igsh=MWJyM2h6NmE2azZkYg==
1 · Reply
taxplanr
taxplanr Jan. 3 at 7:19 PM
If you took the C19 jabs and had a reaction in your arm this is important for you $BNTX $MRNA $PFE https://www.instagram.com/reel/DS_s5GWia9H/?igsh=cnYxbm9qc2M4aDMz
1 · Reply
JuggernautRaider
JuggernautRaider Jan. 3 at 4:00 PM
$ALT how about this @SBL71 ? Durso’s probably meeting with $SNY $PFE and $GILD at JP Morgan this month. Don’t warn the AltImmune bears and short sellers though… their tears will be delicious 🤤
1 · Reply
taxplanr
taxplanr Jan. 3 at 3:06 PM
ACIP chairman condemns prior CDC COVID jab data manipulation $BNTX $MRNA $PFE https://www.malone.news/p/dmed-and-cdc-covid-data-scandals
0 · Reply
Latest News on PFE
Pfizer 2026: The Reset Year

Jan 2, 2026, 2:52 PM EST - 2 days ago

Pfizer 2026: The Reset Year

3 ultra-high-yield stocks to consider for $300 of dividend income in 2026

Dec 31, 2025, 8:37 AM EST - 4 days ago

3 ultra-high-yield stocks to consider for $300 of dividend income in 2026

AGNC PFLT

Exclusive: Drugmakers raise US prices on 350 medicines despite pressure from Trump

Dec 31, 2025, 6:08 AM EST - 4 days ago

Exclusive: Drugmakers raise US prices on 350 medicines despite pressure from Trump

GSK LLY NVS SNY

Chevron, Kimberly-Clark Among 16 Companies To Kick Off 2026 With Annual Dividend Increases In January

Dec 26, 2025, 10:35 PM EST - 8 days ago

Chevron, Kimberly-Clark Among 16 Companies To Kick Off 2026 With Annual Dividend Increases In January

CVX KMB ABM ABT AMGN AVGO BCPC

Pfizer says patient dies after receiving hemophilia drug in trial

Dec 23, 2025, 11:24 AM EST - 12 days ago

Pfizer says patient dies after receiving hemophilia drug in trial

Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound

Dec 19, 2025, 11:45 AM EST - 16 days ago

Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound

Trump to announce new drug-pricing deals later today

Dec 19, 2025, 10:45 AM EST - 16 days ago

Trump to announce new drug-pricing deals later today

ABBV AMGN AZN BMY GILD LLY MRK

Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts

Dec 18, 2025, 10:00 AM EST - 17 days ago

Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts

Pfizer Plays Catchup In Obesity Market, Licenses Weight-loss Drug From Fosun

Dec 18, 2025, 6:58 AM EST - 17 days ago

Pfizer Plays Catchup In Obesity Market, Licenses Weight-loss Drug From Fosun

AbbVie, several other pharma companies near MFN deal with Trump, sources say

Dec 17, 2025, 4:11 PM EST - 18 days ago

AbbVie, several other pharma companies near MFN deal with Trump, sources say

ABBV AMGN AZN BMY LLY NVS

Pfizer Stock Can Sink More. Here Is How

Dec 17, 2025, 2:36 PM EST - 18 days ago

Pfizer Stock Can Sink More. Here Is How

Pfizer, Merck Are Boring Again — And That's Exactly Why 2026 Investors Are Circling Back

Dec 17, 2025, 10:14 AM EST - 18 days ago

Pfizer, Merck Are Boring Again — And That's Exactly Why 2026 Investors Are Circling Back

MRK

PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Dec 17, 2025, 6:45 AM EST - 18 days ago

PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript

Dec 16, 2025, 2:39 PM EST - 19 days ago

Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript

Pfizer falls on disappointing guidance

Dec 16, 2025, 12:33 PM EST - 19 days ago

Pfizer falls on disappointing guidance

Pfizer's modest 2026 outlook shows its big investments will take time to pay off

Dec 16, 2025, 10:12 AM EST - 19 days ago

Pfizer's modest 2026 outlook shows its big investments will take time to pay off

Here's why Pfizer is revising its revenue forecasts

Dec 16, 2025, 7:47 AM EST - 19 days ago

Here's why Pfizer is revising its revenue forecasts

Pfizer Stock Edges Higher on 2026 Guidance. Expect a Rough Year for Covid Vaccine Sales.

Dec 16, 2025, 7:25 AM EST - 19 days ago

Pfizer Stock Edges Higher on 2026 Guidance. Expect a Rough Year for Covid Vaccine Sales.

Pfizer Expects Decline in Covid-19 Drug Demand to Hurt 2026 Earnings

Dec 16, 2025, 7:16 AM EST - 19 days ago

Pfizer Expects Decline in Covid-19 Drug Demand to Hurt 2026 Earnings

Pfizer forecasts 2026 profit below expectations on lower COVID product sales

Dec 16, 2025, 6:54 AM EST - 19 days ago

Pfizer forecasts 2026 profit below expectations on lower COVID product sales

Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance

Dec 16, 2025, 6:45 AM EST - 19 days ago

Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance

Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million

Dec 15, 2025, 8:24 AM EST - 20 days ago

Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million

ADPT

Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer

Dec 15, 2025, 8:00 AM EST - 20 days ago

Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer

ADPT

Pfizer Declares First-Quarter 2026 Dividend

Dec 12, 2025, 12:00 PM EST - 23 days ago

Pfizer Declares First-Quarter 2026 Dividend

Dividend Harvesting Portfolio Week 249: $24,900 Allocated, $2,646.53 In Projected Dividends

Dec 12, 2025, 8:45 AM EST - 23 days ago

Dividend Harvesting Portfolio Week 249: $24,900 Allocated, $2,646.53 In Projected Dividends

AMLP MO MSTY OHI

Health Rounds: Pfizer drug delays progression of advanced breast cancer in trial

Dec 12, 2025, 7:24 AM EST - 23 days ago

Health Rounds: Pfizer drug delays progression of advanced breast cancer in trial

Pfizer to cut hundreds of jobs in Switzerland to reduce costs, Bloomberg News reports

Dec 10, 2025, 11:38 AM EST - 25 days ago

Pfizer to cut hundreds of jobs in Switzerland to reduce costs, Bloomberg News reports

TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer

Dec 10, 2025, 8:15 AM EST - 25 days ago

TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer

Will Pfizer's YaoPharma deal deliver a powerful new oral obesity pill?

Dec 9, 2025, 3:30 PM EST - 26 days ago

Will Pfizer's YaoPharma deal deliver a powerful new oral obesity pill?

Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company's pill

Dec 9, 2025, 11:14 AM EST - 26 days ago

Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company's pill

Undisclosed Deaths in the Pfizer mRNA COVID-19 Vaccine Trial Discussed in the Journal of American Physicians and Surgeons

Dec 9, 2025, 10:59 AM EST - 26 days ago

Undisclosed Deaths in the Pfizer mRNA COVID-19 Vaccine Trial Discussed in the Journal of American Physicians and Surgeons

Pfizer: The Most Powerful Drug Pipeline In Pharma Could Deliver Major Long-Term Gains

Dec 9, 2025, 10:45 AM EST - 26 days ago

Pfizer: The Most Powerful Drug Pipeline In Pharma Could Deliver Major Long-Term Gains

Here's 12 Ideal 'Safer' December Dividend Dogs Of The S&P500

Dec 9, 2025, 10:15 AM EST - 26 days ago

Here's 12 Ideal 'Safer' December Dividend Dogs Of The S&P500

AES AMCR ARE CAG CPB D DOC

Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement

Dec 9, 2025, 6:55 AM EST - 26 days ago

Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement

Pfizer partners with YaoPharma for weight management treatment

Dec 9, 2025, 6:38 AM EST - 26 days ago

Pfizer partners with YaoPharma for weight management treatment

Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma

Dec 9, 2025, 6:30 AM EST - 26 days ago

Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma

HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors

Dec 6, 2025, 5:15 PM EST - 4 weeks ago

HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors

Pfizer: The Market Is Still Wrong About It

Dec 5, 2025, 9:00 AM EST - 4 weeks ago

Pfizer: The Market Is Still Wrong About It

17 dividend-stock bargains from a value manager with a stellar track record

Dec 2, 2025, 12:11 PM EST - 4 weeks ago

17 dividend-stock bargains from a value manager with a stellar track record

BMY CIVI CMCSA CVS MOS MRK MTH

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

Dec 1, 2025, 3:50 PM EST - 4 weeks ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

BNTX MRNA NVAX

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

Dec 1, 2025, 12:35 PM EST - 4 weeks ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

BNTX MRNA NVAX

Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance

Dec 1, 2025, 10:00 AM EST - 4 weeks ago

Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance

Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters

Nov 30, 2025, 6:13 AM EST - 5 weeks ago

Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters

Pfizer, Mastercard Among 24 Companies To Announce Annual Increases In December

Nov 29, 2025, 11:59 PM EST - 5 weeks ago

Pfizer, Mastercard Among 24 Companies To Announce Annual Increases In December

MA AVGO

8 'Safer' Dividend Buys In Barron's 23 Better November Bets Than T-Bills

Nov 28, 2025, 11:00 AM EST - 5 weeks ago

8 'Safer' Dividend Buys In Barron's 23 Better November Bets Than T-Bills

BBB BBY BMY CAG EQR KEY KIM

Final Trade: DAL, AXP, PFE, HMY

Nov 26, 2025, 6:20 PM EST - 5 weeks ago

Final Trade: DAL, AXP, PFE, HMY

AXP DAL HMY

Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings

Nov 26, 2025, 12:30 PM EST - 5 weeks ago

Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings

VALN

JNJ Stock vs. PFE Stock: Which Pharmaceutical Giant Is A Better Buy?

Nov 25, 2025, 5:20 AM EST - 5 weeks ago

JNJ Stock vs. PFE Stock: Which Pharmaceutical Giant Is A Better Buy?

JNJ

U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer

Nov 21, 2025, 1:24 PM EST - 6 weeks ago

U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer

Pfizer Crosses Below Key Moving Average Level

Nov 20, 2025, 4:05 PM EST - 6 weeks ago

Pfizer Crosses Below Key Moving Average Level

JuggernautRaider
JuggernautRaider Jan. 4 at 9:06 PM
I’d be surprised if $NUVB is sold in 2026, but not shocked. Hung’s prior company Medivation sold to $PFE in 2016 after it was clear to their board that they didn’t have a choice. $SNY tried to buy Medvation on the cheap, and then Pfizer blew them out of the water with an offer $30 higher per share. Now, Hung has a fortune and is the largest shareholder of Nuvation by far. So he is better prepared to stay independent if that is his main goal. Some Nuvation bulls believe and want NUVB will stay independent- if they can keep finding deals like the AmHeart deal for a best in class asset like Ibtrozi then they should). I hope both NUVB and $TNXP stay independent for a while, for very different reasons. But I doubt a buyout happens this year for Nuvation given how much Hung learned from his Medivation experience.
1 · Reply
Makingmillions192
Makingmillions192 Jan. 4 at 2:38 PM
$LEXX Bottom line: we are clearly at an inflection point for this company. MTA partner has continued to show interest and the data is compelling and worth continuing. We are also at the stage where we could see new partners get involved. Very exciting times ahead 💰  $JAZZ $PFE $MRK
0 · Reply
Turbofueled
Turbofueled Jan. 4 at 1:23 PM
$LEXX Let the games begin!! I would bet bidding wars are starting! Bring It! $NVO $LLY $AZN $PFE Lets Go $LEXX
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Jan. 4 at 8:13 AM
Enter: $PFE Calls Strike Price: $26 Expiry Date: JAN 30 2026 Buy in Price: $0.20 - $0.20 Sell Price: $0.44 Profit : +122% (Turn every $1 into $2.22) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
clan
clan Jan. 4 at 7:57 AM
$MRK $PFE There's inhalable mealtime insulin. Who knew? $CIPLA.NSE
0 · Reply
twilley
twilley Jan. 4 at 4:38 AM
$PFE Pfizer acquired Amplyx in 2021. Their drug Fosmanogepix could be the next breakthrough for the Candida Auris outbreaks that are current anti fungal drug resistant.
0 · Reply
taxplanr
taxplanr Jan. 4 at 3:27 AM
Sounds like the ground work for liability for COVID jabs from $BNTX $MRNA $PFE https://www.instagram.com/reel/DTCBxDYExIc/?igsh=MWJyM2h6NmE2azZkYg==
1 · Reply
taxplanr
taxplanr Jan. 3 at 7:19 PM
If you took the C19 jabs and had a reaction in your arm this is important for you $BNTX $MRNA $PFE https://www.instagram.com/reel/DS_s5GWia9H/?igsh=cnYxbm9qc2M4aDMz
1 · Reply
JuggernautRaider
JuggernautRaider Jan. 3 at 4:00 PM
$ALT how about this @SBL71 ? Durso’s probably meeting with $SNY $PFE and $GILD at JP Morgan this month. Don’t warn the AltImmune bears and short sellers though… their tears will be delicious 🤤
1 · Reply
taxplanr
taxplanr Jan. 3 at 3:06 PM
ACIP chairman condemns prior CDC COVID jab data manipulation $BNTX $MRNA $PFE https://www.malone.news/p/dmed-and-cdc-covid-data-scandals
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Jan. 3 at 7:24 AM
Enter: $PFE Calls Strike Price: $26 Expiry Date: JAN 23 2026 Buy in Price: $0.16 - $0.17 Sell Price: $0.29 Profit : +82% (Turn every $1 into $1.82) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/pricing
0 · Reply
Paulzk
Paulzk Jan. 3 at 3:24 AM
$PFE In terms of valuation, Pfizer is presently being traded at a Forward P/E ratio of 8.2. This represents a discount compared to its industry average Forward P/E of 14.5. https://finance.yahoo.com/news/pfizer-pfe-outpaces-stock-market-224503053.html
0 · Reply
reyofhope
reyofhope Jan. 3 at 12:07 AM
$PFE I bought some Campbell soup stock today. Interesting to sell Pfizer at 26. Who so low?
0 · Reply
Willieberich
Willieberich Jan. 2 at 11:26 PM
$PFE good luck people ! Everything isn't rosy in the market .this is a safe play ..
0 · Reply
Willieberich
Willieberich Jan. 2 at 11:25 PM
$PFE some want 26 .I want 30 .I have patience. I'll stay here for a nice dividend .soon and if I sell some .I will shift that money to kraft heinz stock for another almost 7 percent dividend the following month .then back to here ..play the dividend game ..
1 · Reply
Willieberich
Willieberich Jan. 2 at 11:19 PM
$PFE tell your sister ! I'm buying
0 · Reply
DipNrip75
DipNrip75 Jan. 2 at 10:43 PM
$PFE $JAZZ $TLRY $ELTP I just commented earlier this week saying wouldn’t it be nice to get a surprise M&A announcement with a deal between Tilly and Phizer. I live near Toronto Ontario and drive by Phizer’s massive manufacturing facilities and between Tilray being Canadian and the US going S3 the probability of a merger just hit multiples. Don’t get caught with your pants down shorties!!! 🩳🌈🐻🐻 to be exact 🤣
0 · Reply
sister
sister Jan. 2 at 10:19 PM
$MRNA $PFE of one thing you can be sure regardless of Calendar Flip . . . Can always get these cheaper. $NVO too
0 · Reply
Justrise07
Justrise07 Jan. 2 at 9:45 PM
$IRWD stay alert for rally ! News is big for value Monday opening 8 $PFE $GSK $MLTX
0 · Reply
The_Wealth_Maker
The_Wealth_Maker Jan. 2 at 9:37 PM
$LEXX $NVO $PFE
0 · Reply
TechTraderGrok
TechTraderGrok Jan. 2 at 9:04 PM
Bought $PFE at $25.16. From Grok: "Reload long on oversold bounce past $26; fresh Phase 3 obesity data from Metsera beats endpoints (18% weight loss), flu vax headlines, and 7.5% yield fueling rebound past guidance dip." https://www.techtrader.ai/grokwall/?post=15975&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
SeriouslyWhy
SeriouslyWhy Jan. 2 at 9:02 PM
$PFE gets back over $26 I’m out fuck this pos
0 · Reply